Hanina Hibshoosh, MD

Expertise in: 
Breast Cancer
Board Certifications: 
Pathology - Anatomic
Accepting New Patients
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Breast Cancer, Breast Pathology

Academic Appointments

  • Professor of Pathology & Cell Biology at CUMC

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Male

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Local 1199

  • Local 1199

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • New York Medical College
  • Residency: Columbia Presbyterian Medical Center, NY
  • Fellowship: Columbia Presbyterian Medical Center, NY

Board Certifications

  • Pathology - Anatomic

Research

Grants

BREAST CANCER FAMILY REGISTRY COHORT (Federal Gov)

May 1 2018 - Apr 30 2023

EARLY DETECTION OF OVARIAN CANCER THROUGH EPIGENETIC FACTORS IN THE WHI (Federal Gov)

Mar 8 2016 - Feb 28 2021

IMMUNE REGULATION OF TRIPLE NEGATIVE BREAST CANCER METASTASIS (Private)

Jul 18 2017 - Jul 17 2020

A PROSPECTIVE, RANDOMIZED STUDY TO COMPARE EFFECTS OF ULIPIRISTAL ACETATE WITH A COMBINED ORAL CONTRACEPTIVE ON BREAST EPITHELIAL CELL PROLIFERATION (Federal Gov)

Jun 17 2016 - Jun 30 2020

COLUMBIA UNIVERSITY MINORITY/UNDERSERVED SITE NCI COMMUNITY ONCOLOGY RESEARCH PROGRAM (Federal Gov)

Aug 1 2014 - Jul 31 2019

CANCER CENTER SUPPORT GRANT (Federal Gov)

Jul 1 2014 - Jun 30 2019

INSULIN RESISTANCE AND BREAST CANCER PROGNOSIS IN BLACK & WHITE WOMEN (Federal Gov)

Jul 9 2012 - Apr 30 2017

CHARACTERIZING THE FUNCTIONAL SIGNIFICANCE OF THE HIGHLY PROGNOSTIC FGD-3 METAGENE IN BREAST CANCER (Federal Gov)

Aug 1 2014 - Jul 31 2016

CHARACTERIZING THE FUNCTIONAL SIGNIFICANCE OF THE HIGHLY PROGNOSTIC FGD3-SUSD3 METAGENE IN BREAST CANCER (Private)

Jun 1 2014 - May 31 2016

CHARACTERIZING THE FUNCTIONAL SIGNIFICANCE OF THE HIGHLY PROGNOSTIC FGD3-SUSD3 METAGENE IN BREAST CANCER (Private)

Jun 1 2014 - May 31 2016

MOLECULAR PATHOGENESIS OF BASAL-LIKE BREAST CANCER (Federal Gov)

Jul 1 2002 - Aug 31 2015

OPTIMIZING MSNP FOR PROFILING DNA METHYLATION IN CANCERS AND PRECURSOR LESIONS (Federal Gov)

Aug 1 2009 - Jul 31 2011

METROPOLITAN NEW YORK REGISTRY OF BREAST CANCER FAMILIES (Federal Gov)

Sep 30 1995 - Jun 30 2011